Next Article in Journal
Safety and Efficacy of Nirsevimab in a Universal Prevention Program of Respiratory Syncytial Virus Bronchiolitis in Newborns and Infants in the First Year of Life in the Valle d’Aosta Region, Italy, in the 2023–2024 Epidemic Season
Previous Article in Journal
Safety and Efficacy of VIT against Wasp Venom in Ultra-Rush Protocols in Patients Older Than 60 Years
 
 
Systematic Review

Article Versions Notes

Vaccines 2024, 12(5), 548; https://doi.org/10.3390/vaccines12050548
Action Date Notes Link
article xml file uploaded 17 May 2024 07:56 CEST Original file -
article xml uploaded. 17 May 2024 07:56 CEST Update https://www.mdpi.com/2076-393X/12/5/548/xml
article pdf uploaded. 17 May 2024 07:56 CEST Version of Record https://www.mdpi.com/2076-393X/12/5/548/pdf
article supplementary file uploaded. 17 May 2024 07:56 CEST - https://www.mdpi.com/2076-393X/12/5/548#supplementary
article html file updated 17 May 2024 07:59 CEST Original file https://www.mdpi.com/2076-393X/12/5/548/html
Back to TopTop